187 related articles for article (PubMed ID: 37532831)
1. Immunosuppressive effect of small extracellular vesicle PD-L1 is restricted by co-expression of CD80.
Liu JY; Yu ZL; Fu QY; Zhang LZ; Li JB; Wu M; Liu B; Chen G
Br J Cancer; 2023 Oct; 129(6):925-934. PubMed ID: 37532831
[TBL] [Abstract][Full Text] [Related]
2. HRS Regulates Small Extracellular Vesicle PD-L1 Secretion and Is Associated with Anti-PD-1 Treatment Efficacy.
Xiao BL; Wang XL; Xia HF; Zhang LZ; Wang KM; Chen ZK; Zhong YH; Jiang HG; Zhou FX; Wang W; Chen GL; Chen G
Cancer Immunol Res; 2023 Feb; 11(2):228-240. PubMed ID: 36484721
[TBL] [Abstract][Full Text] [Related]
3. WJMSC-derived small extracellular vesicle enhance T cell suppression through PD-L1.
Li M; Soder R; Abhyankar S; Abdelhakim H; Braun MW; Trinidad CV; Pathak HB; Pessetto Z; Deighan C; Ganguly S; Dawn B; McGuirk J; Dunavin N; Godwin AK
J Extracell Vesicles; 2021 Feb; 10(4):e12067. PubMed ID: 33598108
[TBL] [Abstract][Full Text] [Related]
4. PD-1/CD80
Zhang LZ; Yang JG; Chen GL; Xie QH; Fu QY; Xia HF; Li YC; Huang J; Li Y; Wu M; Liu HM; Wang FB; Yi KZ; Jiang HG; Zhou FX; Wang W; Yu ZL; Zhang W; Zhong YH; Bian Z; Yang HY; Liu B; Chen G
Nat Commun; 2024 May; 15(1):3884. PubMed ID: 38719909
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Immunoregulatory Biomarkers on Plasma Small Extracellular Vesicles for Disease Progression and Early Therapeutic Response in Head and Neck Cancer.
Jablonska J; Rist M; Spyra I; Tengler L; Domnich M; Kansy B; Giebel B; Thakur BK; Rotter N; Lang S; Ludwig S
Cells; 2022 Mar; 11(5):. PubMed ID: 35269524
[TBL] [Abstract][Full Text] [Related]
6. Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.
Tsai HI; Wu Y; Liu X; Xu Z; Liu L; Wang C; Zhang H; Huang Y; Wang L; Zhang W; Su D; Khan FU; Zhu X; Yang R; Pang Y; Eriksson JE; Zhu H; Wang D; Jia B; Cheng F; Chen H
Adv Sci (Weinh); 2022 Jan; 9(3):e2102634. PubMed ID: 34738731
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-Assisted Traceless Isolation of PD-L1-Positive Small Extracellular Vesicles for Dissecting Their Subpopulation Signature and Function.
Xu R; Yu ZL; Liu XC; Xie QH; Wu M; Chen G
Anal Chem; 2023 Jan; 95(2):1016-1026. PubMed ID: 36534080
[TBL] [Abstract][Full Text] [Related]
8. Association between spatial distribution of leukocyte subsets and clinical presentation of head and neck squamous cell carcinoma.
Netzer C; von Arps-Aubert V; Mačinković I; von der Grün J; Küffer S; Ströbel P; von Knethen A; Weigert A; Beutner D
Front Immunol; 2023; 14():1240394. PubMed ID: 38322012
[TBL] [Abstract][Full Text] [Related]
9. PD-1 Carried on Small Extracellular Vesicles Leads to OSCC Metastasis.
Zhang LZ; Yang JG; Xia HF; Huang J; Liu HM; Wu M; Liu B; Wang WM; Chen G
J Dent Res; 2023 Jul; 102(7):795-805. PubMed ID: 37246810
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Derived Small Extracellular Vesicles Induce Pro-Inflammatory Cytokine Expression and PD-L1 Regulation in M0 Macrophages via IL-6/STAT3 and TLR4 Signaling Pathways.
Pucci M; Raimondo S; Urzì O; Moschetti M; Di Bella MA; Conigliaro A; Caccamo N; La Manna MP; Fontana S; Alessandro R
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829995
[TBL] [Abstract][Full Text] [Related]
11. PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.
Hirata-Nozaki Y; Ohkuri T; Ohara K; Kumai T; Nagata M; Harabuchi S; Kosaka A; Nagato T; Ishibashi K; Oikawa K; Aoki N; Ohara M; Harabuchi Y; Uno Y; Takei H; Celis E; Kobayashi H
J Transl Med; 2019 Jun; 17(1):207. PubMed ID: 31221178
[TBL] [Abstract][Full Text] [Related]
12. Small extracellular vesicles derived from PD-L1-modified mesenchymal stem cell promote Tregs differentiation and prolong allograft survival.
Ou Q; Dou X; Tang J; Wu P; Pan D
Cell Tissue Res; 2022 Sep; 389(3):465-481. PubMed ID: 35688948
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery.
Jung D; Shin S; Kang SM; Jung I; Ryu S; Noh S; Choi SJ; Jeong J; Lee BY; Kim KS; Kim CS; Yoon JH; Lee CH; Bucher F; Kim YN; Im SH; Song BJ; Yea K; Baek MC
J Extracell Vesicles; 2022 Dec; 11(12):e12287. PubMed ID: 36447429
[TBL] [Abstract][Full Text] [Related]
14. Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage.
Wei F; Fang R; Lyu K; Liao J; Long Y; Yang J; Wen W; Sun W
Oral Oncol; 2023 Oct; 145():106532. PubMed ID: 37499326
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived small extracellular vesicles promote breast cancer progression by upregulating PD-L1 expression in macrophages.
Xu D; Chen WQ; Liang MX; Chen X; Liu Z; Fei YJ; Shao XY; Wu Y; Zhang W; Tang JH
Cancer Cell Int; 2023 Jul; 23(1):137. PubMed ID: 37452413
[TBL] [Abstract][Full Text] [Related]
16. CD73 in small extracellular vesicles derived from HNSCC defines tumour-associated immunosuppression mediated by macrophages in the microenvironment.
Lu T; Zhang Z; Zhang J; Pan X; Zhu X; Wang X; Li Z; Ruan M; Li H; Chen W; Yan M
J Extracell Vesicles; 2022 May; 11(5):e12218. PubMed ID: 35524455
[TBL] [Abstract][Full Text] [Related]
17. The Concordant Disruption of B7/CD28 Immune Regulators Predicts the Prognosis of Oral Carcinomas.
Chang SR; Chou CH; Liu CJ; Lin YC; Tu HF; Chang KW; Lin SC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983005
[TBL] [Abstract][Full Text] [Related]
18. TLR9 Mediated Tumor-Stroma Interactions in Human Papilloma Virus (HPV)-Positive Head and Neck Squamous Cell Carcinoma Up-Regulate PD-L1 and PD-L2.
Baruah P; Bullenkamp J; Wilson POG; Lee M; Kaski JC; Dumitriu IE
Front Immunol; 2019; 10():1644. PubMed ID: 31379843
[No Abstract] [Full Text] [Related]
19. Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.
Yin Y; Liu B; Cao Y; Yao S; Liu Y; Jin G; Qin Y; Chen Y; Cui K; Zhou L; Bian Z; Fei B; Huang S; Huang Z
Adv Sci (Weinh); 2022 Mar; 9(9):2102620. PubMed ID: 35356153
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.
Succaria F; Kvistborg P; Stein JE; Engle EL; McMiller TL; Rooper LM; Thompson E; Berger AE; van den Brekel M; Zuur CL; Haanen J; Topalian SL; Taube JM
Cancer Immunol Immunother; 2021 May; 70(5):1227-1237. PubMed ID: 33125511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
